News

VolitionRx Limited Announces Closing of $16.5 Million Underwritten Public Offering of Common Stock

by

HENDERSON, Nev., June 5, 2023 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, announced today the closing of its previously announced underwritten public offering of its common stock generating gross proceeds to Volition from the offering of approximately $16.5 million, before deducting underwriting commissions and other offering expenses payable by Volition. All … Read more

On Lok Partners with San Francisco Health Plan to provide Enhanced Care Management to Eligible Medi-Cal Enrollees

by

SAN FRANCISCO, June 5, 2023 /PRNewswire/ — On Lok is partnering with San Francisco Health Plan (SFHP) to provide Enhanced Care Management (ECM) to SFHP members starting May 1. A new Medi-Cal benefit offered through CalAIM (California Advancing and Innovating Medi-Cal), ECM provides intensive coordination of health and health-related services to high-risk enrollees. CalAIM is … Read more

MEDSIR Study Finds No Progression-Free Survival Benefit with Palbociclib Maintenance After First-Line Regimen in HR+/HER2- Advanced Breast Cancer Patients

by

JERSEY CITY, N.J., June 5, 2023 /PRNewswire/ — MEDSIR announced today the results of the PALMIRA trial. This randomized phase 2 study evaluated the safety and efficacy of palbociclib maintenance in combination with second-line endocrine therapy in patients with hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer who had showed a confirmed progressive disease on first-line palbociclib … Read more

Dragonfly Therapeutics anuncia los resultados del aumento de dosis de DF1001 TriNKET® en ASCO 2023

by

-Dragonfly Therapeutics anuncia la presentación de la fase 1 de los resultados del aumento de dosis de DF1001 TriNKET® en la reunión anual de ASCO 2023 En la Sesión de Terapéutica del Desarrollo – Inmunoterapia de ASCO, el Dr. Howard Safran presenta datos alentadores sobre el estudio de fase 1/2 de Dragonfly de DF1001, un … Read more

Dante Genomics ofrece un nuevo paquete de salud para enfermedades raras

by

-Dante Genomics ofrece un nuevo paquete de salud para enfermedades raras para ayudar a brindar diagnósticos a los millones de personas que viven con enfermedades raras y poner fin a lo que pueden ser odiseas de diagnóstico de años – La nueva oferta brindará a los pacientes y sus familias los diagnósticos definitivos necesarios y … Read more

Bill to Improve Outcomes for Kids with Complex Mental Health Needs Becomes Law

by

Organizations focused on child health collaborated to ensure this program will help kids receive mental health support in the right place, at the right time DENVER, June 5, 2023 /PRNewswire/ — Today Governor Jared Polis signed into law House Bill 23-1269 to improve outcomes for kids with complex mental health needs.  Across the state each month, dozens … Read more

Janssen Presents Longer-Term Data for TECVAYLI® (teclistamab-cqyv) Showing a Duration of Response of 22 Months in Patients with Relapsed or Refractory Multiple Myeloma

by

More than 60 percent of patients achieved an overall response and 45.5 percent of patients achieved a complete response or better by nearly five months Additional data highlights strong efficacy with biweekly TECVAYLI® dosing and show strategies for improving cytokine release syndrome with prophylactic tocilizumab CHICAGO, June 5, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson … Read more

Dante Genomics bietet Patienten mit seltenen Erkrankungen ein neues Gesundheitspaket an, um den Millionen von Menschen, die an einer seltenen Erkrankung leiden, Diagnosen bereitzustellen und die oft jahrelangen diagnostischen Odysseen zu beenden USA – Deutsch USA – English USA – English

by

– Das neue Angebot wird den Patienten und ihren Familien die erforderlichen endgültigen Diagnosen liefern und ihnen ermöglichen, ein besseres Verständnis ihrer Erkrankung zu erhalten – NEW YORK, 5. Juni 2023 /PRNewswire/ — Dante Genomics, ein weltweit führendes Unternehmen im Bereich Genomik und Präzisionsmedizin, gab heute die Einführung seines Gesundheitspakets für seltene Erkrankungen bekannt, das die … Read more